Informations sur le produit
- (5'beta)-5'-[(2S)-butan-2-yl]-12'-hydroxy-3',6',18-trioxo-2'-(propan-2-yl)ergotaman
- (5′α)-12′-Hydroxy-2′-(1-methylethyl)-5′-[(1S)-1-methylpropyl]ergotaman-3′,6′,18-trione
- 5'alpha(S)-sec-Butyl-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione
- 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3′,6′,18-trione deriv.
- Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-(1-methylpropyl)-, [5′α(S)]-
- Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-[(1S)-1-methylpropyl]-, (5′α)-
- Indolo[4,3-fg]quinoline, ergotaman-3′,6′,18-trione deriv.
- beta-Ergocryptine
- beta-Ergokryptine
- β-Ergocryptine
- Voir d'autres synonymes
- β-Ergokryptine
Ergocryptine is a drug that is used to treat Parkinson’s disease. It is an active metabolite of the ergot alkaloid ergometrine. It has been shown in studies using polyclonal antibodies and casein to inhibit spontaneous activity in rats, as well as citric acid production from perennial ryegrass. Ergocryptine also inhibits biosynthesis of ergocryptine and chemical ionization of peptones from purpurea strain. It is structurally similar to ergometrine, but it does not have the same physiological effects because it lacks the methyl group on the nitrogen atom at position 2.
Propriétés chimiques
Question d’ordre technique sur : 3D-FE40777 b-Ergocryptine
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages